Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Oncology

T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Colorado

The Colorado Blood Cancer Institute
Denver Colorado 80218

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Florida

Florida Cancer Specialists
Sarasota Florida 34232

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Massachusetts

Dana Farber Cancer Institute
Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of PEG-L-asparaginase and Dexamethasone acetate to evaluate T-Cell Lymphoma, Relapsed T-Cell Lymphoma or Refractory T-Cell Lymphoma

Michigan

Detroit Clinical Research Center, PC
Novi Michigan 48377

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

New York

New York Presbyterian Hospital
New York New York 10021

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Memorial Sloan-Kettering Cancer Center
New York New York 10065

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Oklahoma

Oklahoma University
Oklahoma City Oklahoma 73104

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Tennessee

Tennessee Oncology, PLLC
Nashville Tennessee 37203

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Australia

Royal Adelaide Hospital
Adelaide South Australia 5000

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Flinders Medical Center
Bedford Park South Australia 5042

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Monash Medical Centre
Clayton Victoria 3168

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Saint Vincent's Hospital Melbourne
Fitzroy Victoria 3109

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Frankston Hospital
Frankston Victoria 3199

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

View More »

Royal Hobart Hospital
Hobart Tasmania 7001

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Cabrini Health
Malvern Victoria 3144

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Royal Perth Hospital
Perth Western Australia 6000

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Belgium

AZ Sint-Jan
Brugge 8000

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Universitair Ziekenhuis Gent
Gent 9000

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Canada

Hôpital du Sacré-Coeur de Montréal
Montreal Quebec H4J 1C5

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Sunnybrook Health Science Centre
Toronto Ontario M4N 3M5

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

France

Hôpital Morvan
Brest 29609

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

CHU Haut-Leveque
Pessac 33604

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Israel

Hadassah Ein-Kerem Medical Centre
Jerusalem 91120

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Shaare Zedek Medical Center
Jerusalem 91031

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Rabin Medical Center
Petach Tikva 49100

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Chaim Sheba Medical Center
Tel Hashomer 52621

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Italy

Az. Ospedaliera Universitaria S. Orsola Malpighi
Bologna 40138

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Spedali Civili di Brescia
Brescia 25123

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Meldola Forli 47014

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Rhizen Trial Site
Milano

Patients are needed to participate in a clinical research study evaluating RP6530 for the treatment of Lymphoma, B-Cell or T-Cell Lymphoma

Ospedale S. Maria delle Croci
Ravenna 48121

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

View More »

Az. Ospedaliera Università Senese
Siena 53100

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

New Zealand

Auckland City Hospital / Auckland University
Auckland 1010

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Christchurch Hospital
Christchurch 8011

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

North Shore Hospital
Milford

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Middlemore Hospital
Otahuhu Auckland 1640

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Poland

Dept of Hematology and Transplantology
Gdansk 80-952

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Małopolskie Centrum Medyczne
Kraków 30-510

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Klinika Nowotworów Ukladu Chlonnego Centrum Onkologii Instytut Marii Sklodowskiej-Curie
Warszawa Mazowieckie 02-781

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Puerto Rico

Auxilio Mutuo Cancer Center
San Juan 00918

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Spain

Hospital Clínic i Provincial de Barcelona
Barcelona 08036

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Hospital General Vall d'Hebron
Barcelona 08035

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Hospital Universitario Ramón y Cajal
Madrid 28034

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Hospital de Madrid Norte-Sanchinarro
Madrid 28050

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Madrid 28222

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

View More »

Clinica Universidad de Navarra
Pamplona Navarra 31008

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Complejo Hospitalario de Navarra, Servicio de Hematologia
Pamplona Navarra 31008

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

United Kingdom

Belfast City Hospital
Belfast BT9 7AB

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Velindre Hospital
Cardiff CF14 2TL

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Antrim Area Hospital
County Antrim Northern Ireland BT41 2RL

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

First 1 2 Last